Skip to content
Liver Fellow Network

Liver Fellow Network

education and collaboration for hepatology trainees

Menu
  • Home
  • Core Series
    • Clinical Pearls
    • Pathology Pearls
    • Journal Club
    • Tweetorials
    • Visuals
  • About Us
    • Our Team
  • Mail
  • Search
  • Follow Us
    • Twitter
    • E-mail us

Tag: hepatic encephalopathy

Posted onJuly 6, 2021November 22, 2021The Why? Series

Why do we use Lactulose and Rifaximin for Hepatic Encephalopathy?

by Alyson KaplanLeave a comment on Why do we use Lactulose and Rifaximin for Hepatic Encephalopathy?

Lactulose and Rifaximin (Xifaxan) are standards of care for the prevention of overt hepatic encephalopathy in patients with cirrhosis. Have you ever wondered why? Join…

Read More
Posted onNovember 11, 2020November 15, 2020Evidence Corner

Does the addition of rifaximin to lactulose improve outcomes in overt hepatic encephalopathy?

by Lizzie AbyLeave a comment on Does the addition of rifaximin to lactulose improve outcomes in overt hepatic encephalopathy?

A review of the study on rifaximin as an adjunctive therapy in treatment of hepatic encephalopathy.

Read More
Posted onNovember 8, 2020November 15, 2020Evidence Corner

Is PEG as good as lactulose for treating inpatients with hepatic encephalopathy?

by Alex VogelLeave a comment on Is PEG as good as lactulose for treating inpatients with hepatic encephalopathy?

Can polyethylene glycol (PEG) be used to treat hepatic encephalopathy in hospitalized patients?

Read More
Posted onAugust 16, 2020August 31, 2020Tools of the Trade

Quick Tips: Hepatic Encephalopathy

by Lizzie AbyLeave a comment on Quick Tips: Hepatic Encephalopathy

The latest installment in the LFN Quick Tips series involves hepatic encephalopathy. How is it identified? What are common precipitants? How can it be treated (besides with lactulose!)?

Read More

Sign up to receive e-mail updates when we post new content!

* = required field
unsubscribe from list
Amphibious Theme by TemplatePocket ⋅ Powered by WordPress